Insider Transactions in Q3 2024 at Verona Pharma PLC (VRNA)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 11
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
600,000
-4.02%
|
$1,800,000
$3.76 P/Share
|
|
Sep 11
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
600,000
-3.79%
|
$1,800,000
$3.76 P/Share
|
|
Aug 13
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
398,400
-1.3%
|
$1,195,200
$3.23 P/Share
|
|
Aug 13
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
398,400
-1.23%
|
$1,195,200
$3.23 P/Share
|
|
Aug 12
2024
|
David R Ebsworth Director |
BUY
Open market or private purchase
|
Direct |
36,000
+3.93%
|
$72,000
$2.87 P/Share
|
|
Aug 12
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,600
-0.01%
|
$4,800
$3.13 P/Share
|
|
Aug 12
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
1,600
-0.01%
|
$4,800
$3.13 P/Share
|
|
Aug 07
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
314,800
-2.01%
|
$629,600
$2.62 P/Share
|
|
Aug 07
2024
|
Mark W Hahn Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
800,000
+4.86%
|
-
|
|
Aug 07
2024
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
87,904
-3.24%
|
$175,808
$2.62 P/Share
|
|
Aug 07
2024
|
Kathleen A. Rickard Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+6.86%
|
-
|
|
Aug 07
2024
|
David Zaccardelli President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
314,800
-1.9%
|
$629,600
$2.62 P/Share
|
|
Aug 07
2024
|
David Zaccardelli President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
800,000
+4.61%
|
-
|
|
Aug 01
2024
|
David Zaccardelli President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
88,544
-0.56%
|
$177,088
$2.83 P/Share
|
|
Aug 01
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
88,544
-0.59%
|
$177,088
$2.83 P/Share
|
|
Aug 01
2024
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
106,232
-4.05%
|
$212,464
$2.83 P/Share
|